Intriguingly, Tukey-Kramer analysis revealed a significant difference in serum LECT2 levels in HCC patients when compared to chronic liver disease patients with cirrhosis (p = 0.0017) and healthy volunteers (p = 0.0078) (Figure 4A). The gene discussed is LECT2; the disease is hepatocellular carcinoma.